A fish cytokine related to human IL-3, IL-5, and GM-CSF, induces development of eosinophil/basophil/mast-cell type (EBM) granulocytes.
Interleukin-3 (IL-3), IL-5, and granulocyte-macrophage colony-stimulating issue (GM-CSF) are related cytokines that sign by way of receptors possessing the β frequent (βc) chain. As a household, these cytokines mix quite non-specific hematopoietic progress issue properties with a particular significance for eosinophils, basophils, and mast cells. In fish the cytokines of this household are known as IL-5fam, and the current examine, utilizing carp, constitutes their first useful evaluation.
Carp il-5fam expression was enhanced by stimulation with phytohemagglutinin and killed micro organism. Reminiscent of mammalian IL-3/IL-5/GM-CSF relations, recombinant carp IL-5fam (rcIL-5fam) induced activation of transcription issue STAT5 and effectively promoted proliferation and colony-formation of eosinophil/basophil/mast-cell type (EBM) granulocytes.
Upon addition of recombinant carp βc the expansion impact of rcIL-5fam was diminished, suggesting βc participation within the signaling route. In abstract, regardless of variations in particular person cytokines and cell populations, fish and mammalian IL-3/IL-5/GM-CSF relations share progress issue features for non-neutrophil granulocytes.
Clinical Physicians’ Attitudes in direction of Evidence-Based Medicine (EBM) and Their Evidence-Based Practice (EBP) in Wuhan, China.
Objective: Numerous research have proved the significance of Evidence-Based Medicine (EBM) in each day scientific observe, nevertheless, clinicians’ attitudes play an vital position in figuring out its implementation. The goal of this examine was to examine Chinese scientific physicians’ notion of and angle in direction of EBM and their Evidence-Based Practice (EBP) in addition to the obstacles in direction of EBP. Methods: Using a cross-sectional design, self-response questionnaires have been distributed to scientific physicians (inside medication and surgical procedure departments) throughout three tertiary hospitals in Wuhan, China. Results: In complete, 131 out of 195 (67.2%) physicians accomplished and returned the questionnaire.
A complete of 64.9% of the physicians both knew reasonably or rather a lot about EBM. The imply rating of physicians’ angle towards EBM was 2.35 ± 0.35, and that of their EBP talent/ competency was 1.51 ± 0.56 (on 0-3 Likert scale). In complete, 76.0% of physicians typically or generally utilized EBM in routine each day observe. The largest barrier stopping implementation was the various particular person variations in ailments (61.0%), adopted by a scarcity of funding from the hospital/division (39.8%), and a scarcity of affected person cooperation (37.4%). Chinese physicians in tertiary hospitals possessed expressed optimistic attitudes in direction of EBM; nevertheless, they solely retained a average stage of scientific proof competency.
Both a person issue (private curiosity) and organizational elements (workload, hospital requirement) had an impact on physicians’ attitudes and their EBP expertise. Management and organizational efforts, as well as to time devoted for EBP initiatives may assist scale back obstacles that stop EBP.
SARC-F Validation and SARC-F+EBM Derivation in Musculoskeletal Disease: The SPSS-OK Study.
To validate the SARC-F questionnaire for sarcopenia screening in musculoskeletal illness setting, and to assess enhancements in diagnostic accuracy by including “EBM” (aged and physique mass index info) to the SARC-F.Diagnostic accuracy examine.The heart concerned on this examine was situated in an city space of Kobe City, Japan. People with musculoskeletal illness within the knee, hip, or backbone who have been scheduled for surgical remedy have been included.Sarcopenia was evaluated utilizing the Asian Working Group for Sarcopenia (AWGS) and the European Working Group on Sarcopenia in Older People (EWGSOP2), which included bioimpedance, handgrip energy, and gait pace. Patients answered the SARC-F questionnaire and their physique mass index was measured. SARC-F and “EBM” info have been mixed into an authentic rating.
The sensitivities, specificities, and areas below the receiver working attribute curve (AUC) have been estimated and in contrast to determine sarcopenia.A complete of 959 sufferers have been included. Sarcopenia by AWGS standards was recognized in 36 (3.8%) sufferers. SARC-F had a sensitivity of 41.7% and specificity of 68.5%. SARC-F+EBM had a sensitivity of 77.8% and specificity of 69.6%, with substantial enchancment in sensitivity (P<0.001). The AUCs for SARC-F and SARC-F+EBM have been 0.557 (95% confidence interval [CI] 0.452-0.662) and 0.824 (95% CI 0.762-0.886), respectively (P<0.001).
Similar outcomes have been obtained when EWGSOP2 standards have been used because the reference normal.The SARC-F alone just isn’t ample for locating circumstances in musculoskeletal illness settings. SARC-F+EBM considerably improved the sensitivity and general diagnostic accuracy of the SARC-F for screening sarcopenia. SARC-F+EBM is probably helpful for screening sarcopenia in numerous ethnic and illness settings.
A comparative examine on the nanoindentation habits, put on resistance and in vitro biocompatibility of SLM manufactured CP-Ti and EBM manufactured Ti64 gyroid scaffolds.
The current examine investigates the nanoindentation habits, put on resistance and in vitro biocompatibility of SLM manufactured CP-Ti and EBM manufactured Ti64 gyroid scaffolds and the outcomes have been in contrast to these of casting CP-Ti. Both the SLM- and EBM manufactured scaffolds exhibited anisotropic properties with greater diminished modulus (up to 10%) and nanohardness (up to 30%) within the transverse course than these in constructing course. The put on resistance of scaffolds in transverse course was greater than these of in constructing course by up to ∼25% and ∼82% for SLM manufactured CP-Ti and EBM manufactured Ti64 scaffolds, respectively.
The SLM manufactured CP-Ti scaffolds displayed important enhancement in put on resistance over solid dense CP-Ti with 75% decrease imply worn peak throughout a nanowear take a look at. The coefficient of friction was various between 0.11 and 0.24 and exhibited a gentle imply worth of 0.15-0.18 for CP-Ti and Ti64 scaffolds, respectively. During in vitro cell tradition examine, CP-Ti scaffolds confirmed greater cell viability and cell adhesion density compared to Ti64 scaffolds for all unit cell sizes.
Moreover, cell adhesion density of scaffolds with smaller unit cell sizes (G2) are decrease than these of bigger unit cells (G3). SEM observations confirmed that each the internal area and surfaces of gyroid scaffolds offered an appropriate setting for cell migration, attachment and proliferation after cell tradition for 7 d. STATEMENT OF SIGNIFICANCE: It is crucial to consider the properties of EBM/SLM manufactured scaffolds and to decide whether or not they can meet the robust efficiency necessities of the biomedical trade.
 Stable Cell Line) MDA-MB-231 / Luciferase (Bsd) Stable Cell Line |
|||
| SC059-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1500 |
|
Description: Luciferase (firefly) expression stable cell line in MDA-MB-231 cells with Blasticidin resistance |
|||
 Stable Cell Line) MDA-MB-231 / Luciferase (Puro) Stable Cell Line |
|||
| SC059-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1500 |
|
Description: Luciferase (firefly) expression stable cell line in MDA-MB-231 cells with Puromycin resistance |
|||
 MDA-MB-231 cells |
|||
| C0006002 | Addexbio | One Frozen vial | EUR 455 |
 MDA-MB-468 cells |
|||
| C0006003 | Addexbio | One Frozen vial | EUR 455 |
 MDA-MB-175VII cells |
|||
| C0006009 | Addexbio | One Frozen vial | EUR 485 |
 MDA-MB-157 cells |
|||
| C0006020 | Addexbio | One Frozen vial | EUR 455 |
 MDA-MB-231 / Luciferase-2A-RFP Stable Cell Line |
|||
| SC041 | GenTarget | 2 x 106 cell/ml x 1ml | EUR 2225 |
|
Description: Firefly luciferase and GFP co-expression stable cell line in MDA-MB-231 cells with Blasticidin resistance |
|||
 MDA-MB-231 / Luciferase-2A-GFP Stable Cell Line |
|||
| SC044 | GenTarget | 2 x 106 cell/ml x 1ml | EUR 2225 |
|
Description: Luciferase (firefry) and GFP co-expression stable cell line in MDA-MB-231 human breast cancer cell line with Puromycin marker. |
|||
 lysate) Human MDA-MB-361 (Breast Adenocarcinoma) lysate |
|||
| HCL-1217 | Alpha Diagnostics | 100ug | EUR 238 |
 MDA-BSA Control |
|||
| STA-333 | Cell Biolabs | 100 µg | EUR 322 |
|
Description:
|
|||
) Human CK-MB ELISA Kit (Creatine Kinase-MB) |
|||
| PRB-5047 | Cell Biolabs | 96 assays | EUR 572 |
|
Description: Our Human CK-MB ELISA Kit specifically detects the CK-MB form of Creatine Kinase in serum or plasma samples as well as in lysates. The kit does not detect the CK-MM or CK-BB isotypes. Each kit provides sufficient reagents for 96 wells including standards and unknown samples. |
|||
Human CK-MB ELISA Kit (Creatine Kinase-MB) |
|||
| PRB-5047-5 | Cell Biolabs | 5 x 96 assays | EUR 2283 |
|
Description: Our Human CK-MB ELISA Kit specifically detects the CK-MB form of Creatine Kinase in serum or plasma samples as well as in lysates. The kit does not detect the CK-MM or CK-BB isotypes. Each kit provides sufficient reagents for 96 wells including standards and unknown samples. |
|||
 Modified Human Albumin) Malondialdehyde (MDA) Modified Human Albumin |
|||
| STA-210 | Cell Biolabs | 100 µg | EUR 421 |
|
Description:
|
|||
 OxiSelect MDA Immunoblot Kit |
|||
| STA-331 | Cell Biolabs | 10 blots | EUR 554 |
|
Description: MDA, or malondialdehyde, is a widely accepted marker for oxidative stress. Our OxiSelect MDA Immunoblot Kit provides a specific method for detection of this lipid peroxidation by-product. Important Note: MDA adducts are not stable long term. For best results test all samples immediately upon collection, or freeze them at -80ºC for up to one month. MDA may be degraded in samples that have been frozen for longer periods; in such cases more reliable results may be obtained from more stable markers of oxidative stress such as protein carbonyl, 8-OHdG or 4-HNE. |
|||
 stable cells) MDA-MB-231 / TetR (Puro) stable cells |
|||
| SC040-TetR | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1210 |
|
Description: Tetracycline repressor expression stable cell line with Puromycin marker in MDA-MB-231 human breast cancer cells. |
|||
 EBM 3'UTR Luciferase Stable Cell Line |
|||
| TU006522 | ABM | 1.0 ml | EUR 2333 |
 EBM 3'UTR GFP Stable Cell Line |
|||
| TU056522 | ABM | 1.0 ml | EUR 2333 |
 Modified Human Apolipoprotein B-100) Malondialdehyde (MDA) Modified Human Apolipoprotein B-100 |
|||
| STA-211 | Cell Biolabs | 100 µg | EUR 624 |
|
Description:
|
|||
 Gene Knock-Out HR Targeting Vector [MCS1-EF1?-RFP-T2A-Puro-pA-MCS2] |
|||
| HR110PA-1 | SBI | 10 ug | EUR 1023 |
|
|||
 Gene Knock-Out HR Targeting Vector [MCS1-EF1a-GFP-T2A-Puro-pA-MCS2] |
|||
| HR410PA-1 | SBI | 10 ug | EUR 1023 |
|
|||
 Gene Knock-Out HR Targeting Vector [MCS1-EF1a-RFP-T2A-Hygro-pA-MCS2] |
|||
| HR510PA-1 | SBI | 10 ug | EUR 1023 |
|
|||
 MDA-MB-231 Human breast cancer, aggressive/invasive/metastatic cell line: >1x10^10 frozen exosomes |
|||
| EXOP-105A-1 | SBI | 50 ug | EUR 467 |
|
|||
 Polyclonal Antibody) Goat Anti-Malondialdehyde (MDA) Polyclonal Antibody |
|||
| STA-031 | Cell Biolabs | 100 µg | EUR 508 |
|
Description: Goat Anti-Malondialdehyde Polyclonal Antibody is Affinity purified and suitable for Western blot or ELISA. Suitable for use with any species. 100 µg. |
|||
 Polyclonal Antibody) Rabbit Anti-Malondialdehyde (MDA) Polyclonal Antibody |
|||
| STA-032 | Cell Biolabs | 100 µg | EUR 508 |
|
Description: Rabbit Anti-Malondialdehyde Polyclonal Antibody is Affinity purified and suitable for Western blot or ELISA. Suitable for use with any species. 100 µg. |
|||
) OxiSelect TBARS Assay Kit (MDA Quantitation) |
|||
| STA-330 | Cell Biolabs | 200 assays | EUR 659 |
|
Description: The TBARS (Thiobarbituric Acid Reactive Substances) assay is well-established for screening and monitoring lipid peroxidation. MDA forms a 1:2 adduct with thiobarbituric acid; the MDA-TBA adduct can then be measured. Our OxiSelect TBARS Assay Kit provides a much more user-friendly protocol to measure the MDA-TBA adduct. Reaction volumes are much smaller than the traditional assay, so much less sample is required. Also, reactions can be performed in standard polypropylene tubes - no glass tubes or glass marbles are required. Important Note: MDA adducts are not stable long term. For best results test all samples immediately upon collection, or freeze them at -80ºC for up to one month. MDA may be degraded in samples that have been frozen for longer periods; in such cases more reliable results may be obtained from more stable markers of oxidative stress such as protein carbonyl, 8-OHdG or 4-HNE. |
|||
OxiSelect TBARS Assay Kit (MDA Quantitation) |
|||
| STA-330-5 | Cell Biolabs | 5 x 200 assays | EUR 2671 |
|
Description: The TBARS (Thiobarbituric Acid Reactive Substances) assay is well-established for screening and monitoring lipid peroxidation. MDA forms a 1:2 adduct with thiobarbituric acid; the MDA-TBA adduct can then be measured. Our OxiSelect TBARS Assay Kit provides a much more user-friendly protocol to measure the MDA-TBA adduct. Reaction volumes are much smaller than the traditional assay, so much less sample is required. Also, reactions can be performed in standard polypropylene tubes - no glass tubes or glass marbles are required. Important Note: MDA adducts are not stable long term. For best results test all samples immediately upon collection, or freeze them at -80ºC for up to one month. MDA may be degraded in samples that have been frozen for longer periods; in such cases more reliable results may be obtained from more stable markers of oxidative stress such as protein carbonyl, 8-OHdG or 4-HNE. |
|||
 OxiSelect MDA Adduct Competitive ELISA Kit |
|||
| STA-832 | Cell Biolabs | 96 assays | EUR 798 |
|
Description: MDA, or malondialdehyde, is a widely accepted marker for oxidative stress. Our OxiSelect MDA Competitive ELISA Kit provides a sensitive, specific method for detection of this lipid peroxidation by-product. Important Note: MDA adducts are not stable long term. For best results test all samples immediately upon collection, or freeze them at -80ºC for up to one month. MDA may be degraded in samples that have been frozen for longer periods; in such cases more reliable results may be obtained from more stable markers of oxidative stress such as protein carbonyl, 8-OHdG or 4-HNE. |
|||
OxiSelect MDA Adduct Competitive ELISA Kit |
|||
| STA-832-5 | Cell Biolabs | 5 x 96 assays | EUR 3240 |
|
Description: MDA, or malondialdehyde, is a widely accepted marker for oxidative stress. Our OxiSelect MDA Competitive ELISA Kit provides a sensitive, specific method for detection of this lipid peroxidation by-product. Important Note: MDA adducts are not stable long term. For best results test all samples immediately upon collection, or freeze them at -80ºC for up to one month. MDA may be degraded in samples that have been frozen for longer periods; in such cases more reliable results may be obtained from more stable markers of oxidative stress such as protein carbonyl, 8-OHdG or 4-HNE. |
|||
) TARGATT? Knock-in iPSC Generation (Master Cell Line) |
|||
| AST-1100 | Applied StemCell | 1 vial of 1X10^6 cells | Ask for price |
|
Description: 6 month |
|||
) TARGATT? Knock-in Mouse Cell Line Generation Kit (Master Cell Line) |
|||
| AST-7001 | Applied StemCell | 1 Kit | Ask for price |
|
Description: 6 month |
|||
) OxiSelect Human Oxidized LDL ELISA Kit (MDA-LDL Quantitation) |
|||
| STA-369 | Cell Biolabs | 96 assays | EUR 780 |
|
Description: LDL, so-called "bad cholesterol", is even more dangerous when it becomes oxidized. Oxidized LDL (OxLDL) is more reactive with surrounding tissues and can collect within the inner-lining of arteries. Macrophages, cholesterol, and other lipids can accumulate at the site (atherosclerosis), ultimately forming a plaque that can lead to heart attack, stroke or death. Oxidation of LDL affects both the lipid and protein components of LDL. The OxiSelect Human Oxidized LDL ELISA Kits are enzyme immunoassays developed for the detection and quantitation of human oxLDL in plasma, serum or other biological fluid samples. The kits contain a copper oxidized LDL standard against which unknown samples may be compared. This oxidized LDL assay kit is configured to selectively measure oxLDL in MDA-LDL. |
|||
) OxiSelect Human Oxidized HDL ELISA Kit (MDA-HDL Quantitation) |
|||
| STA-869 | Cell Biolabs | 96 assays | EUR 780 |
|
Description: The OxiSelect Human Oxidized HDL ELISA Kits are enzyme immunoassays developed for the detection and quantitation of human oxHDL in plasma, serum or other biological fluid samples. This oxidized HDL assay kit is configured to selectively measure MDA-modified HDL. The kit contains an MDA-HDL standard against which unknown samples may be compared. Note: For samples stored for more than one month, better results may be obtained with measurement of CML or HNE modifications, both of which are more stable than MDA. |
|||
 Modified Low Density Lipoprotein (LDL)) Malondialdehyde (MDA) Modified Low Density Lipoprotein (LDL) |
|||
| STA-212 | Cell Biolabs | 100 µg | EUR 450 |
|
Description:
|
|||
) EBM Recombinant Protein (Human) |
|||
| RP055977 | ABM | 100 ug | Ask for price |
) TARGATT? Knock-in CHO Generation Kit (Master Cell Line) |
|||
| AST-1200 | Applied StemCell | 1 Kit | Ask for price |
|
Description: 12 month |
|||
) TARGATT? Knock-in HEK293 Generation Kit (Master Cell Line) |
|||
| AST-1300 | Applied StemCell | 1 Kit | Ask for price |
|
Description: 12 month |
|||
) EBM sgRNA CRISPR Lentivector set (Human) |
|||
| K0650101 | ABM | 3 x 1.0 ug | EUR 339 |
, Trial Size) OxiSelect TBARS Assay Kit (MDA Quantitation), Trial Size |
|||
| STA-330-T | Cell Biolabs | 20 assays | EUR 340 |
|
Description: The TBARS (Thiobarbituric Acid Reactive Substances) assay is well-established for screening and monitoring lipid peroxidation. MDA forms a 1:2 adduct with thiobarbituric acid; the MDA-TBA adduct can then be measured. Our OxiSelect TBARS Assay Kit provides a much more user-friendly protocol to measure the MDA-TBA adduct. Reaction volumes are much smaller than the traditional assay, so much less sample is required. Also, reactions can be performed in standard polypropylene tubes - no glass tubes or glass marbles are required. Important Note: MDA adducts are not stable long term. For best results test all samples immediately upon collection, or freeze them at -80ºC for up to one month. MDA may be degraded in samples that have been frozen for longer periods; in such cases more reliable results may be obtained from more stable markers of oxidative stress such as protein carbonyl, 8-OHdG or 4-HNE. |
|||
 OxiSelect MDA Adduct Competitive ELISA Kit, Trial Size |
|||
| STA-832-T | Cell Biolabs | 32 assays | EUR 421 |
|
Description: MDA, or malondialdehyde, is a widely accepted marker for oxidative stress. Our OxiSelect MDA Competitive ELISA Kit provides a sensitive, specific method for detection of this lipid peroxidation by-product. Important Note: MDA adducts are not stable long term. For best results test all samples immediately upon collection, or freeze them at -80ºC for up to one month. MDA may be degraded in samples that have been frozen for longer periods; in such cases more reliable results may be obtained from more stable markers of oxidative stress such as protein carbonyl, 8-OHdG or 4-HNE. |
|||
 Basic HR Targeting Vector [MCS1-LoxP-MCS2-MCS3-pA-LoxP-MCS4] for Gene Knock-In/Out |
|||
| HR100PA-1 | SBI | 10 ug | EUR 938 |
|
|||
 (Target 1)) EBM sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K0650102 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 2)) EBM sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K0650103 | ABM | 1.0 ug DNA | EUR 154 |
 (Target 3)) EBM sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K0650104 | ABM | 1.0 ug DNA | EUR 154 |
 (pORF)) EBM ORF Vector (Human) (pORF) |
|||
| ORF018660 | ABM | 1.0 ug DNA | Ask for price |
 293AD Cell Line |
|||
| AD-100 | Cell Biolabs | 1 vial | EUR 461 |
|
Description: The 293AD Cell Line is derived from the parental 293 cells but selected for attributes that increase adenovirus production, including firmer attachment and larger surface area. |
|||
 293AAV Cell Line |
|||
| AAV-100 | Cell Biolabs | 1 vial | EUR 508 |
|
Description: The 293AAV Cell Line is derived from the parental 293 cells but selected for attributes that increase AAV production, including firmer attachment and larger surface area. |
|||
 293LTV Cell Line |
|||
| LTV-100 | Cell Biolabs | 1 vial | EUR 508 |
|
Description: The 293LTV Cell Line is derived from the parental 293 cells but selected for attributes that increase lentiviral production, including fimrer attachment and larger surface area. |
|||
 293RTV Cell Line |
|||
| RV-100 | Cell Biolabs | 1 vial | EUR 508 |
|
Description: The 293RTV Cell Line is derived from the parental 293 cells but selected for attributes that increase retroviral production, including fimrer attachment and larger surface area. |
|||
 Mb 3'UTR GFP Stable Cell Line |
|||
| TU162951 | ABM | 1.0 ml | Ask for price |
 Mb 3'UTR Luciferase Stable Cell Line |
|||
| TU212917 | ABM | 1.0 ml | Ask for price |
 MB 3'UTR Luciferase Stable Cell Line |
|||
| TU013059 | ABM | 1.0 ml | EUR 1394 |
Mb 3'UTR Luciferase Stable Cell Line |
|||
| TU112951 | ABM | 1.0 ml | Ask for price |
 MB 3'UTR GFP Stable Cell Line |
|||
| TU063059 | ABM | 1.0 ml | EUR 1394 |
Mb 3'UTR GFP Stable Cell Line |
|||
| TU262917 | ABM | 1.0 ml | Ask for price |
 Microplate Swing-Out Centrifuge |
|||
| abx725026-1Unit | Abbexa | 1 Unit | EUR 1476 |
|
|||
 Clinical Swing-Out Centrifuge |
|||
| abx725027-1Unit | Abbexa | 1 Unit | EUR 1476 |
|
|||
 and Negative Selection (TK) Against Random Integration) Gene Knock-Out HR Targeting Vector w/Single Selection Marker (Blasticidin) and Negative Selection (TK) Against Random Integration |
|||
| HR720PA-1 | SBI | 10 µg | EUR 1145 |
|
|||
 293/GFP Cell Line |
|||
| AKR-200 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: 293/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
 T47D/GFP Cell Line |
|||
| AKR-208 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: T47D/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
 A549/GFP Cell Line |
|||
| AKR-209 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: A549/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
 HeLa/GFP Cell Line |
|||
| AKR-213 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: HeLa/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
 NIH3T3/GFP Cell Line |
|||
| AKR-214 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: NIH3T3/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
 NIH3T3/Cas9 Cell Line |
|||
| AKR-5104 | Cell Biolabs | 1 vial | EUR 572 |
 293/Cas9 Cell Line |
|||
| AKR-5110 | Cell Biolabs | 1 vial | EUR 572 |
 HeLa/Cas9 Cell Line |
|||
| AKR-5111 | Cell Biolabs | 1 vial | EUR 572 |
 MDA 19 |
|||
| HY-15451 | MedChemExpress | 5mg | EUR 126 |
 and Negative Selection (TK) Against Random Integration) Gene Knock-Out HR Targeting Vector w/Dual Selection Markers (GFP+Puro) and Negative Selection (TK) Against Random Integration |
|||
| HR700PA-1 | SBI | 10 µg | EUR 1145 |
|
|||
 and Negative Selection (TK) Against Random Integration) Gene Knock-Out HR Targeting Vector w/Dual Selection Markers (RFP+Hygro) and Negative Selection (TK) Against Random Integration |
|||
| HR710PA-1 | SBI | 10 µg | EUR 1145 |
|
|||
 SKOV-3/Luc Cell Line |
|||
| AKR-232 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: SKOV-3/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
|||
 MCF-7/Luc Cell Line |
|||
| AKR-234 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: MCF-7/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
|||
 OVCAR-5/RFP Cell Line |
|||
| AKR-254 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: OVCAR-5/RFP Cell Line stably expresses RFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
 Human MDA ELISA Kit |
|||
| EHM0030 | Abclonal | 96Tests | EUR 521 |
Human MDA ELISA Kit |
|||
| EHM0265 | Abclonal | 96Tests | EUR 521 |
Human MDA ELISA Kit |
|||
| ELA-E0597h | Lifescience Market | 96 Tests | EUR 824 |
 MDA ELISA KIT|Human |
|||
| EF007363 | Lifescience Market | 96 Tests | EUR 689 |
 Gene Knock-Out HR Targeting Vector with TK selection [MCS1-LoxP-EF1?-GFP-T2A-Puro-P2A-hsvTK-pA-LoxP-MCS2] |
|||
| HR210PA-1 | SBI | 10 ug | EUR 1145 |
|
|||
 (pPB-C-His)) EBM Protein Vector (Human) (pPB-C-His) |
|||
| PV074637 | ABM | 500 ng | Ask for price |
 (pPB-N-His)) EBM Protein Vector (Human) (pPB-N-His) |
|||
| PV074638 | ABM | 500 ng | Ask for price |
 (pPM-C-HA)) EBM Protein Vector (Human) (pPM-C-HA) |
|||
| PV074639 | ABM | 500 ng | Ask for price |
 (pPM-C-His)) EBM Protein Vector (Human) (pPM-C-His) |
|||
| PV074640 | ABM | 500 ng | Ask for price |
 Monoclonal Anti-Human C1q protein IgG biotinylated |
|||
| C1Q12-MB | Alpha Diagnostics | 50 ug | EUR 408 |
 Platinum-E Retroviral Packaging Cell Line, Ecotropic |
|||
| RV-101 | Cell Biolabs | 1 vial | EUR 920 |
|
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-E cells contain gag, pol and env genes, allowing retroviral packaging with a single plasmid transfection. |
|||
 Platinum-A Retroviral Packaging Cell Line, Amphotropic |
|||
| RV-102 | Cell Biolabs | 1 vial | EUR 920 |
|
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-A cells contain gag, pol and env genes, allowing retroviral packaging with a single plasmid transfection. |
|||
 Platinum-GP Retroviral Packaging Cell Line, Pantropic |
|||
| RV-103 | Cell Biolabs | 1 vial | EUR 920 |
|
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-GP cells contain the gag and pol genes required for retroviral packaging; an expression vector is co-transfected with a VSVG envelope vector. |
|||
) EBM sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K0650105 | ABM | 3 x 1.0 ug | EUR 376 |
 TARGATT? Knock-in iPSC Genotyping Kit |
|||
| AST-1102 | Applied StemCell | 1 Kit | Ask for price |
|
Description: 12 month |
|||
 Antibody) Malondialdehyde (MDA) Antibody |
|||
| 20-abx130475 | Abbexa |
|
|
|
|||
Malondialdehyde (MDA) Antibody |
|||
| abx023266-1ml | Abbexa | 1 ml | EUR 565 |
|
|||
 (HSA)) Malondialdehyde (MDA) (HSA) |
|||
| 20-abx281005 | Abbexa |
|
|
|
|||
 MDA Assay Kit |
|||
| 55R-1512 | Fitzgerald | 100 assays | EUR 809 |
|
Description: Assay Kit for detection of MDA in the research laboratory |
|||
 (Human) ELISA Kit) Creatine Kinase MB (CK-MB) (Human) ELISA Kit |
|||
| E4606-100 | Biovision | EUR 729 | |
 ELISA Kit) Human CK-MB(Creatine Kinase MB) ELISA Kit |
|||
| EH0351 | FN Test | 96T | EUR 476.25 |
|
|||
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml |
|||
 Biotinylated-Mouse Monoclonal Anti-Human FLK-1/VEGFR-2 IgG # 3 |
|||
| FLK13-MB | Alpha Diagnostics | 100 ug | EUR 408 |
 Human Beta-Site APP-Cleaving Enzyme 1) Recombinant (E.Coli, His-tag) Human Beta-Site APP-Cleaving Enzyme 1 |
|||
| RP-435 | Alpha Diagnostics | 1 ug | EUR 164 |
 ELISA Kit) Human MDA(Malonyldehyde) ELISA Kit |
|||
| EH4174 | FN Test | 96T | EUR 567.6 |
|
|||
|
Description: Method of detection: Coated with Antigen, Competitive ELISA;Reacts with: Homo sapiens;Sensitivity: 1.875 ng/ml |
|||
ELISA Kit) Human malondialchehyche(MDA)ELISA Kit |
|||
| GA-E1388HM-48T | GenAsia Biotech | 48T | EUR 289 |
Human malondialchehyche(MDA)ELISA Kit |
|||
| GA-E1388HM-96T | GenAsia Biotech | 96T | EUR 466 |
 Human malondialchehyche,MDA ELISA Kit |
|||
| 201-12-1372 | SunredBio | 96 tests | EUR 440 |
|
|||
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
 Human Malondialdehyde, MDA ELISA Kit |
|||
| CELI-66086h | Lifescience Market | 96 Tests | EUR 824 |
Human malondialchehyche(MDA)ELISA Kit |
|||
| QY-E04112 | Qayee Biotechnology | 96T | EUR 361 |
 Antibody) AML1 (Ab-435) Antibody |
|||
| 33271-100ul | SAB | 100ul | EUR 252 |
AML1 (Ab-435) Antibody |
|||
| 33271-50ul | SAB | 50ul | EUR 187 |
 Antibody) RELA (Ab-435) Antibody |
|||
| CSB-PA870451- | Cusabio | EUR 335 | |
|
|||
|
Description: A polyclonal antibody against RELA (Ab-435). Recognizes RELA (Ab-435) from Human, Mouse, Rat, Monkey. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200 |
|||
RELA (Ab-435) Antibody |
|||
| CSB-PA870451-100ul | Cusabio | 100ul | EUR 316 |
|
|||
|
Description: A polyclonal antibody against RELA (Ab-435). Recognizes RELA (Ab-435) from Human, Mouse, Rat, Monkey. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200 |
|||
 Antibody) RUNX1 (Ab-435) Antibody |
|||
| CSB-PA132524- | Cusabio | EUR 335 | |
|
|||
|
Description: A polyclonal antibody against RUNX1 (Ab-435). Recognizes RUNX1 (Ab-435) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
|||
RUNX1 (Ab-435) Antibody |
|||
| CSB-PA132524-100ul | Cusabio | 100ul | EUR 316 |
|
|||
|
Description: A polyclonal antibody against RUNX1 (Ab-435). Recognizes RUNX1 (Ab-435) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
|||
) MB sgRNA CRISPR Lentivector set (Human) |
|||
| K1274001 | ABM | 3 x 1.0 ug | EUR 339 |
 (CMV) (pLenti-GIII-CMV)) EBM Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
|||
| LV723683 | ABM | 1.0 ug DNA | Ask for price |
 (UbC) (pLenti-GIII-UbC)) EBM Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
|||
| LV723687 | ABM | 1.0 ug DNA | Ask for price |
 (EF1a) (pLenti-GIII-EF1a)) EBM Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV723688 | ABM | 1.0 ug DNA | Ask for price |
 Total Protein - Murine Embryonic Stem Cell Line D3 |
|||
| CBA-305 | Cell Biolabs | 500 ?g | EUR 345 |
|
Description:
|
|||
 Whole Cell Lysate) Human MDA-MD-435S (breast cancer) Whole Cell Lysate |
|||
| HCL-2017 | Alpha Diagnostics | 100ug | EUR 213 |
 MB siRNA |
|||
| 20-abx903181 | Abbexa |
|
|
|
|||
 Duocarmycin MB |
|||
| HY-107770 | MedChemExpress | 50mg | EUR 7967 |
MB siRNA |
|||
| 20-abx923683 | Abbexa |
|
|
|
|||
MB siRNA |
|||
| 20-abx923684 | Abbexa |
|
|
|
|||
 MB antibody |
|||
| 70R-35614 | Fitzgerald | 100 ug | EUR 327 |
|
Description: Rabbit polyclonal MB antibody |
|||
 MB Antibody |
|||
| ABD4194 | Lifescience Market | 100 ug | EUR 438 |
MB Antibody |
|||
| ABD7358 | Lifescience Market | 100 ug | EUR 438 |
MB Antibody |
|||
| 34815-100ul | SAB | 100ul | EUR 252 |
MB Antibody |
|||
| 34815-50ul | SAB | 50ul | EUR 187 |
 MB acid |
|||
| 40076 | Biotium | 5MG | EUR 320 |
|
Description: Minimum order quantity: 1 unit of 5MG |
|||
MB Antibody |
|||
| 32870-100ul | SAB | 100ul | EUR 252 |
MB Antibody |
|||
| DF4194 | Affbiotech | 200ul | EUR 304 |
|
Description: MB Antibody detects endogenous levels of total MB. |
|||
MB Antibody |
|||
| DF7358 | Affbiotech | 200ul | EUR 304 |
|
Description: MB Antibody detects endogenous levels of total MB. |
|||
MB Antibody |
|||
| 1-CSB-PA952223 | Cusabio |
|
|
|
|||
|
Description: A polyclonal antibody against MB. Recognizes MB from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:10000, WB:1:1000-1:5000 |
|||
In this examine, nanoindentation and nanowear properties of SLM manufactured CP-Ti and EBM manufactured Ti64 gyroid scaffolds with completely different unit cell sizes and pattern orientations have been evaluated and in contrast to solid dense CP-Ti samples. Moreover, the in vitro biocompatibility of the scaffolds was assessed and in contrast to one another. To our greatest of information, this type of examine on EBM/SLM manufactured CP-Ti and Ti64 scaffolds haven’t been reported, to date.